日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Changes in Cardiovascular Risk Factors and Health Care Expenditures Among Patients Prescribed Semaglutide

接受司美格鲁肽治疗的患者心血管危险因素和医疗保健支出的变化

Lu, Yuan; Liu, Yuntian; Totojani, Tedi; Kim, Chungsoo; Khera, Rohan; Xu, Hua; Brush, John E Jr; Krumholz, Harlan M; Abaluck, Jason

The role of regional and practice trial sites in nonrepresentative randomized cancer trial enrollment

区域和实践试验点在非代表性随机癌症试验入组中的作用

Shah, Sachin J; Manz, Christopher R; Balthis, Brendan; Raman, Hari S; Abaluck, Jason; Keating, Nancy L; Agha, Leila

RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates

恢复:每晚一次服用羟丁酸的偏好以及每晚两次服用羟丁酸的夜间体验

Roy, Asim; Stern, Thomas; Harsh, John; Hudson, J Douglas; Ajayi, Akinyemi O; Corser, Bruce C; Mignot, Emmanuel; Santamaria, Adrian; Morse, Anne Marie; Abaluck, Brian; Ibrahim, Sally; Schweitzer, Paula K; Lancaster, Katie; Dubow, Jordan; Gudeman, Jennifer

The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial

阿洛西丁宁和阿托莫西汀联合治疗阻塞性睡眠呼吸暂停(MARIPOSA):一项随机对照试验

Schweitzer, Paula K; Taranto-Montemurro, Luigi; Ojile, Joseph M; Thein, Stephen G; Drake, Christopher L; Rosenberg, Russell; Corser, Bruce; Abaluck, Brian; Sangal, R Bart; Maynard, James

Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA

阿托莫西汀与新型抗胆碱能药物阿罗昔布宁联合使用可改善轻度至中度阻塞性睡眠呼吸暂停综合征

Rosenberg, Russell; Abaluck, Brian; Thein, Stephen

Mortality Effects and Choice Across Private Health Insurance Plans

私人医疗保险计划的死亡率影响和选择

Abaluck, Jason; Bravo, Mauricio Caceres; Hull, Peter; Starc, Amanda

NightBalance Sleep Position Treatment Device Versus Auto-Adjusting Positive Airway Pressure for Treatment of Positional Obstructive Sleep Apnea

NightBalance睡眠体位治疗装置与自动调节正压通气治疗体位性阻塞性睡眠呼吸暂停的比较

Berry, Richard B; Uhles, Matthew L; Abaluck, Brian K; Winslow, David H; Schweitzer, Paula K; Gaskins, Raymond A Jr; Doekel, Robert C Jr; Emsellem, Helene A